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Abstract
Modern ventilators are increasingly compact and able to deliver a wide range of
ventilator modes and sophisticated monitoring capabilities. However, the global avail-
ability of ventilators is woefully short of demand. Data on intensive care units (ICUs),
a proxy measure for hospital ventilator capacity in low and middle-income countries
(LMIC's), suggest that capacity is extremely limited where it exists at all. In LMIC's,
the four most common indications for mechanical ventilation (MV) in ICUs are post-
surgical care, sepsis, trauma, and maternal peripartum or neonatal complications.
A significant majority of these cases can be managed with intervention involving a
short course of MV. Widespread and timely access to MV can thus effectively be
used to help patients in these settings and improve outcomes. This paper implores
this need and highlights the requirements for a low-cost ventilator or a respiratory
support device.
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1 | BACKGROUND
Mechanical ventilation (MV) is a mode of invasive organ support used
to maintain adequate lung function in patients with, or at risk of, fail-
ing cardiorespiratory function.1 From Andreas Vesalius' 16th century
accounts of ventilation, negative-pressure reliant iron lungs in the
early 20th century, to the highly sophisticated devices available today,
there has been much development of MV throughout history. The
search for effective MV for paralytic poliomyelitis patients and Acute
Respiratory Distress Syndrome (ARDS) spurred the development of
MV technology reliant on positive-pressure and positive end-
expiratory pressure (PEEP) use.1,2
Modern ventilators are increasingly compact and able to
deliver a wide range of ventilatory modes with sophisticated
monitoring capabilities.2 MV can be classified as invasive or
non-invasive, or classified based on the degree of respiratory
assistance the ventilator provides for the respiratory cycle, as
such: fully controlled, partially assisted, unassisted.2 MV is used
extensively in Intense Care Units (ICU's) and surgical settings.
Indications for MV can be divided into three broad categories:
(a) Reduced level of consciousness (eg, head trauma, drug over-
dose, anesthesia), (b) Respiratory failure (eg, ARDS, COVID-19,
COPD) and (c) Circulatory failure.2
In low-income countries (LMIC's), the four most common indica-
tions requiring MV in ICUs are post-surgical care, sepsis, trauma, and
maternal peripartum or neonatal complications.3 A significant majority
of these cases can be successfully managed with intervention involv-
ing a short course of MV. Widespread access to MV in a timely fash-
ion can thus effectively be used to help patients in these settings and
significantly improve outcomes.3Nitish Nachiappan and Jung Moses Koo are joint first authors.
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2 | GLOBAL CHALLENGES
The Lancet Commission on Global Health in 20134 highlighted the
real possibility of reducing mortality rates of LMICs: to levels at which
a “grand convergence” in health can be reached by 2035, to the level
of current well-performing Middle-Income Countries. This in turn is
predicted to yield proportionally substantial benefits to the economies
of LMICs, with 11% of recent economic growth accounted by a reduc-
tion in mortality. The relative economic benefits exceed the cost of
the initial financial outlay by a factor of 9 to 20 over the 2015 to
2035 period.4 The value of ventilators for both short and longer-term
use in low middle-income countries (LMICs) is clear. However, the
availability of ventilators is woefully short of demand. Data on ICUs, a
proxy measure for hospital ventilator capacity in LMICs, suggest that
capacity is extremely limited where it exists at all. More than 50% of
LMICs do not have any data on ventilator/ICU capacity.5 This high-
lights the fragmentation and limited infrastructure present in these
countries. It is also important to note that the burden of cardiorespira-
tory failure in LMICs may be under represented due to patients in
whom intensive care was never initiated in the first place due to lack
of availability of treatment.6 This urgent need is further highlighted by
the globally unprecedented and escalating SARS-CoV-2 pandemic,7
for which MV has an essential role in treatment.8 As the pandemic
progresses, ventilatory capacity will be completely overwhelmed
in LMICs.9 Even high-income countries such as the US, have struggled
with access to ventilators as the prevalence of SARS-CoV-2 reaches
overwhelmingly high rates.10 In fact, there is growing evidence to
suggest that LMICs with a high SARS-CoV-2 prevalence have
already been suffering such shortages, such as in India,9,11,12 which
has recorded over 10.5 million cases and 150, 000 deaths, as of Janu-
ary 2021.13
Another vital factor to consider is the significant relative shortage
of trained medical staff in LMICs. Estimates by the WHO highlight a
global shortage of 4.3 million medical staff, including doctors, mid-
wives, nurses, and other healthcare workers.14 Seventy-five countries
had fewer than 2.5 health workers per 1000,14 known as the mini-
mum ratio required for basic health services. Most of these shortages
are known to be in LMICs and this imbalance between the supply and
demand of staff is further illustrated in the case of Africa; by 2009
estimates, 1.3% of the world's medical staff has been providing care
for 25% of the global disease burden.15 Multiple reasons for such
shortages exist, such as insufficient infrastructure for clinical educa-
tion and weak regulation of education standards.16 Furthermore,
“brain drain,”14,17: emigration of skilled medical staff from LMICs to
HICs which are perceived to have superior economies, working
conditions, political stability, and more opportunities for career
progression,16 alongside an aging workforce,17 are seen to have dras-
tically exacerbated this issue. Shocking, life-endangering situations in
the African continent have been reported where health services have
vanished overnight due to the sudden emigration of skilled workers.14
It is also thought that this phenomenon not only results in direct loss
of labor supply in the health sector but also results in the consequen-
tial loss of future investments into training and education.18
This situation is further complicated due to healthcare imbalances
present between urban and rural regions in LMICs. In many LMICs,
much of the population inhabit rural areas. However, most large hos-
pitals are located in cities, thereby reducing the population's accessi-
bility to advanced healthcare.19 As a result, critically ill patients in
rural and remote settings are treated in basic ward environments of
regional medical facilities.3,5 Even in those few rural regional hospitals
which have ICUs, the number of beds available is often lower com-
pared to urban ICUs.6 Furthermore, there is a significant shortage of
skilled healthcare professionals capable of providing advanced levels
of care beyond urban concentrations of provision.20 These factors
have all contributed to rural and remote regions in LMICs having
significantly poorer health outcomes, especially in the critically unwell,
and a lower life expectancy compared to both urban regions in LMICs as
well as higher-income countries (HICs).21 The etiology of critical illness is
also different between rural and urban settings. For instance, a common
cause of severe illness in rural LMIC settings is acute neuromuscular
paralysis induced by snakebite venom.22 Annually, it is estimated that 4.5
to 5.4 million people get bitten by snakes, of which 81 000 to 138 000
die from complications.23 Both mortality and morbidity are greatest in
rural communities of LMICs, due to the factors described above.24 MV is
a critical component of the care necessary for envenomation and failure
to access such care results in significant mortality.22,24
The literature clearly suggests that there is a real and urgent need
for a simple, easily maintained, and operated mechanical ventilator or
a respiratory support device to significantly reduce mortality in a wide
range of conditions.
3 | INFRASTRUCTURE FOR HEALTH
SERVICES
Due to the limited healthcare infrastructure present in LMIC's, a
significant amount of medical treatment is likely to occur in low
resource settings. These settings are likely to have limited access to
electricity and compressed oxygen and are likely to be in semi-
permanent structures. In these scenarios, portable respiratory support
devices would be the most effective tool to provide ventilation to
those who need it. The majority of current portable ventilators are
complex and fragile devices that consist of sophisticated hardware
and software. They require trained staff to calibrate, repair, and use
the device. The cost of these devices range from 3300 to 13 500
USD and are therefore beyond the reach of many healthcare systems
even if they could be powered and maintained reliably.25
3.1 | Economic impact related to the age of the
patient
Interestingly, in LMIC populations, younger patients are often dispro-
portionately affected by critical illness compared to the developed
world.26 Each death of a young patient, which otherwise could have
been prevented through timely MV, would translate to the loss of
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many years of potential contribution to the LMIC's economy and pro-
ductivity. Younger patients have reduced short-term and long-term
mortality and morbidity than older patients after critical illness,27 with a
greater likelihood for recovery and productivity. Thus, increased avail-
ability of MVs in LMICs, through the development of an economical
and robust device, will not only benefit the health economy in these
countries but will improve the overall prosperity by saving lives.28
3.2 | Maternal mortality
A woman's lifetime risk of maternal mortality is 1 in 38 in sub-Saharan
Africa, compared to 1 in 5100 in Europe.29 This is despite the UN
Millennium Development Goal 5, an effort by the World Health Orga-
nization (WHO), which aimed to reduce global maternal mortality by
75% and focused on regions with higher maternal mortality. Even
though the global maternal mortality rate was nearly halved in these
efforts, more than half of all maternal deaths worldwide still occur in
Sub-Saharan Africa,30 most commonly due to hemorrhage, pre-
eclampsia/eclampsia, or sepsis.31 According a recently published
report, maternal and neonatal disorders is one of the top five condi-
tions that has the potential for reduction in the disease burden. This
reduction, in this group, can be related to 120 disability-adjusted life
years.28 A key factor that contributes to such devastating mortality
rates is the severe shortage and accessibility of medical and surgical
equipment32 and ventilators,33 further reinforcing the urgent need for
accessible and low-cost MVs.
3.3 | Other critical scenarios
Simple mechanical ventilation would also provide a huge benefit in
the management of road traffic collisions. LMICs are disproportion-
ately affected by road traffic accidents, with 90% of global road traffic
deaths occurring in these countries.34 Literature suggests that 68% of
trauma admissions in the low-income setting require intensive care
support including ventilation.35 As previously established, there is a
distinct lack of ventilator capacity in these settings, so increased avail-
ability of these devices would significantly improve mortality.
4 | THE WAY FORWARD
This all highlights the need to provide a MV that is portable, robust,
and financially viable in LMICs. The WHO specification for a simple
portable ventilator is:
• Air compression
• Oxygen mixing capacity to an accuracy of 4%
• Can generate a FiO2 from 21% to 100%
• Can generate a tidal volume of 20 to 1000 mL (Medicines and
Healthcare products Regulatory Agency, UK regulation is 400
+/ 10%)
• Can generate an I:E ratio of 1:2
• Can generate a respiratory rate of 10 to 60 bpm
• A test function to assess for air leaks
• A display of these parameters
• An alarm function for parameters that fall outside the normal range
• Easily cleaned.
These simple criteria differ from the more complex criteria for
hospital ventilators and can be met by analog devices using basic
technology such as a modified bag valve mask (BVM) or a high-
pressure blower.36
Modern portable ventilators, though effective, are expensive and
therefore inaccessible in many parts of the world. The WHO criteria
above needs to be fulfilled by a simple device which can be marketed
for a significantly lower cost than existing devices. In addition, one
needs to note that the range provided for tidal volumes and the respi-
ratory rates in the WHO specification could be altered depending on
where and how these devices are used. For example, a tidal volume
range of 250 to 550 should be sufficient for adult use in certain emer-
gency scenarios. In terms of respiratory rates, with an I:E of 1:1, a
device which can go up to max 25 bpm could be sufficient in majority
of adult cases.
Ideally, such a device would be locally manufactured and locally
maintained to both mitigate against cost and logistical barriers as well as
augment the local health economy. The use of such a device will need to
be largely intuitive or at least require only fundamental training such that
its use by a variety of healthcare providers is facilitated.
In conclusion, there is a clear and urgent need for simple, low-
cost, portable ventilators or respiratory support devices in LMICs, the
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